Literature DB >> 20452826

Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Chaorui Tian1, Xueli Yuan, Peter T Jindra, Jessamyn Bagley, Mohamed H Sayegh, John Iacomini.   

Abstract

Induction of transplantation tolerance has the potential to allow for allograft acceptance without the need for life-long immunosuppression. Here we describe a novel approach that uses delivery of alloantigen by mature T cells to induce tolerance to fully allogeneic cardiac grafts. Adoptive transfer of mature alloantigen-expressing T cells into myeloablatively conditioned mice results in long-term acceptance of fully allogeneic heart transplants without evidence of chronic rejection. Since myeloablative conditioning is clinically undesirable we further demonstrated that adoptive transfer of mature alloantigen-expressing T cells alone into mice receiving non-myeloablative conditioning resulted in long-term acceptance of fully allogeneic heart allografts with minimal evidence of chronic rejection. Mechanistically, tolerance induction involved both deletion of donor-reactive host T cells and the development of regulatory T cells. Thus, delivery of alloantigen by mature T cells induces tolerance to fully allogeneic organ allografts in non-myeloablatively conditioned recipients, representing a novel approach for tolerance induction in transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452826      PMCID: PMC2991109          DOI: 10.1016/j.clim.2010.04.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  66 in total

1.  Immunity or tolerance: opposite outcomes of microchimerism from skin grafts.

Authors:  C C Anderson; P Matzinger
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

Review 2.  Tolerance and chronic rejection.

Authors:  K L Womer; R S Lee; J C Madsen; M H Sayegh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-05-29       Impact factor: 6.237

Review 3.  Knowledge about transplantation tolerance gained in primates.

Authors:  S J Knechtle
Journal:  Curr Opin Immunol       Date:  2000-10       Impact factor: 7.486

Review 4.  Mixed chimerism and transplantation tolerance.

Authors:  T Wekerle; M Sykes
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

5.  Requirements for induction and maintenance of peripheral tolerance in stringent allograft models.

Authors:  Masayuki Sho; Koji Kishimoto; Hiroshi Harada; Mauren Livak; Alberto Sanchez-Fueyo; Akira Yamada; Xin Xiao Zheng; Terry B Strom; Giacomo P Basadonna; Mohamed H Sayegh; David M Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

6.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

7.  Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.

Authors:  Daron Forman; Chaorui Tian; John Iacomini
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 8.  Signals from dying cells: tolerance induction by the dendritic cell.

Authors:  Thomas A Ferguson; Hirotaka Kazama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 9.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

10.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

View more
  1 in total

Review 1.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.